Molecure Balance Sheet Health
Financial Health criteria checks 6/6
Molecure has a total shareholder equity of PLN164.0M and total debt of PLN0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are PLN175.4M and PLN11.4M respectively.
Key information
0%
Debt to equity ratio
zł0
Debt
Interest coverage ratio | n/a |
Cash | zł84.98m |
Equity | zł164.04m |
Total liabilities | zł11.41m |
Total assets | zł175.45m |
Recent financial health updates
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?
Apr 20We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate
Dec 01Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?
Jul 07Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth
Mar 10Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth
Aug 16Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?
Jan 02Recent updates
Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?
Apr 20We're Keeping An Eye On Molecure's (WSE:MOC) Cash Burn Rate
Dec 01Is Molecure (WSE:MOC) In A Good Position To Invest In Growth?
Jul 07Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth
Mar 10Companies Like Molecure (WSE:MOC) Are In A Position To Invest In Growth
Aug 16OncoArendi Therapeutics' (WSE:OAT) Earnings Are Weaker Than They Seem
Nov 04Is OncoArendi Therapeutics S.A.'s (WSE:OAT) Shareholder Ownership Skewed Towards Insiders?
Feb 24Will OncoArendi Therapeutics (WSE:OAT) Spend Its Cash Wisely?
Jan 02Financial Position Analysis
Short Term Liabilities: MOC's short term assets (PLN87.3M) exceed its short term liabilities (PLN7.8M).
Long Term Liabilities: MOC's short term assets (PLN87.3M) exceed its long term liabilities (PLN3.6M).
Debt to Equity History and Analysis
Debt Level: MOC is debt free.
Reducing Debt: MOC has not had any debt for past 5 years.
Debt Coverage: MOC has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: MOC has no debt, therefore coverage of interest payments is not a concern.